Shared inflammatory architecture and therapeutic tensions between psoriasis and Crohn’s disease

• by Xiaoou Wang, Jitong Li, Keying Yu, Xianbo Wu, Quan Luo

• June 26, 2026

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

• by Kathryn Wighton

• June 11, 2026

• 2 min

Does TYK2/JAK1 Show Potential in Inflammatory Diseases?

Investigational inhibitor was not associated with treatment-related serious adverse events and produced biomarker changes consistent with pathway inhibition in healthy volunteers.

• by Andrea Surnit

• July 6, 2026

• 3 min

Understanding Social Drivers of Health Among US Adults with Psoriasis from Different Races and Ethnicities

• by Victoria Barbosa, Tina Bhutani-Jacques, Valerie D. Callender, Elizabeth D. Bacci, Evangeline Pierce, Beth Mitchell, Julia R. Correll, Nicole Huang

• July 15, 2026